Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-16

FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)

View source ↗

Summary

The FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucotrol XL (glipizide)

Snippet

SUPPL AP for GLUCOTROL XL (GLIPIZIDE)